4551 — Torii Pharmaceutical Co Income Statement
0.000.00%
Last trade - 00:00
- ¥105bn
- ¥63bn
- ¥55bn
- 69
- 53
- 68
- 74
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 42,998 | 41,700 | 46,987 | 48,896 | 54,638 |
Cost of Revenue | |||||
Gross Profit | 22,296 | 21,738 | 24,338 | 23,380 | 24,791 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5,560 | 37,708 | 42,371 | 43,358 | 49,640 |
Operating Profit | 37,438 | 3,992 | 4,616 | 5,538 | 4,998 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 37,700 | 4,225 | 4,767 | 5,722 | 5,593 |
Provision for Income Taxes | |||||
Net Income After Taxes | 27,367 | 3,496 | 3,375 | 3,944 | 4,120 |
Net Income Before Extraordinary Items | |||||
Net Income | 27,367 | 3,496 | 3,375 | 3,944 | 4,120 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 27,367 | 3,495 | 3,374 | 3,944 | 4,119 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 43.8 | 146 | 121 | 140 | 148 |
Dividends per Share |